Target intelligence / Profile preview

Tick-borne Encephalitis Virus (TBEV)

Target
TBEV
Molecular classification
Virus, Flavivirus
01

Overview

Tick-borne encephalitis virus (TBEV) is a positive-sense, single-stranded RNA virus belonging to the genus *Flavivirus*. It is the causative agent of tick-borne encephalitis (TBE), a viral infectious disease that primarily affects the central nervous system and can lead to meningitis, encephalitis, or meningoencephalitis. Transmission occurs primarily through tick bites and, less commonly, through consumption of unpasteurized dairy products. Key proteins include the envelope protein (E) which mediates cell entry and induces protective immunity, capsid protein (C) which forms the nucleocapsid, and non-structural proteins (NS3, NS5) involved in replication. There is no specific antiviral treatment; management focuses on supportive care. Vaccination is available for prevention.

02

Mechanism of action

N/A (no specific antiviral treatment; vaccines induce neutralizing antibodies)

03

Biological functions

Viral replicationInfectionImmune evasion
04

Disease associations

Tick-borne encephalitisMeningitisEncephalitisMeningoencephalitis
05

Safety considerations

Vaccine side effects (rare)Long-term neurological sequelae in infected individualsMortality in severe cases
06

Interacting drugs

Vaccines (TBEV-specific)

1 more in the full profile.

07

Biomarkers

TBEV RNA (detected by PCR)TBEV-specific antibodies (IgM, IgG)

Beyond the preview

Go deeper on Tick-borne Encephalitis Virus (TBEV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tick-borne Encephalitis Virus (TBEV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call